Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence Steinman

Showing results (41-50 of 335) with videos related to

Pageof 34
Sort By:
The Journal of Experimental Medicine|July 2, 2008
A rush to judgment on Th17Lawrence Steinman
The Journal of Clinical Investigation|November 5, 2008
Nuanced roles of cytokines in three major human brain disordersLawrence Steinman
Circulation Research|April 28, 2012
Platelets provide a bounty of potential targets for therapy in multiple sclerosisLawrence Steinman
Nature Reviews. Drug Discovery|June 3, 2005
Blocking adhesion molecules as therapy for multiple sclerosis: natalizumabLawrence Steinman
Nature Immunology|February 19, 2013
A Tip leads cytotoxic T cells to the crime scene in neuroinflammationLawrence Steinman
Nature Immunology|December 18, 2009
Mixed results with modulation of TH-17 cells in human autoimmune diseasesLawrence Steinman
Nature|June 3, 2005
Design of effective immunotherapy for human autoimmunityMarc Feldmann, Lawrence Steinman
Brain : a Journal of Neurology|January 8, 2026
The complexity of interpreting TSPO PET neuroimaging in first-episode psychosisAgnieszka Kalinowski, Lawrence Steinman
Immunology and Cell Biology|January 21, 2018
Nonclassical monocytes: are they the next therapeutic targets in multiple sclerosis?Bahareh Ajami, Lawrence Steinman
Expert Opinion on Investigational Drugs|April 18, 2020
New targets and therapeutics for neuroprotection, remyelination and repair in multiple sclerosisPablo Villoslada, Lawrence Steinman
Pageof 34

Showing results (41-50 of 335) with videos related to

Sort By:
Pageof 34
The Journal of Experimental Medicine|July 2, 2008
A rush to judgment on Th17Lawrence Steinman
The Journal of Clinical Investigation|November 5, 2008
Nuanced roles of cytokines in three major human brain disordersLawrence Steinman
Circulation Research|April 28, 2012
Platelets provide a bounty of potential targets for therapy in multiple sclerosisLawrence Steinman
Nature Reviews. Drug Discovery|June 3, 2005
Blocking adhesion molecules as therapy for multiple sclerosis: natalizumabLawrence Steinman
Nature Immunology|February 19, 2013
A Tip leads cytotoxic T cells to the crime scene in neuroinflammationLawrence Steinman
Nature Immunology|December 18, 2009
Mixed results with modulation of TH-17 cells in human autoimmune diseasesLawrence Steinman
Nature|June 3, 2005
Design of effective immunotherapy for human autoimmunityMarc Feldmann, Lawrence Steinman
Brain : a Journal of Neurology|January 8, 2026
The complexity of interpreting TSPO PET neuroimaging in first-episode psychosisAgnieszka Kalinowski, Lawrence Steinman
Immunology and Cell Biology|January 21, 2018
Nonclassical monocytes: are they the next therapeutic targets in multiple sclerosis?Bahareh Ajami, Lawrence Steinman
Expert Opinion on Investigational Drugs|April 18, 2020
New targets and therapeutics for neuroprotection, remyelination and repair in multiple sclerosisPablo Villoslada, Lawrence Steinman
Pageof 34